148 related articles for article (PubMed ID: 38938663)
1. Applying new approach methodologies to assess next-generation tobacco and nicotine products.
Thorne D; McHugh D; Simms L; Lee KM; Fujimoto H; Moses S; Gaca M
Front Toxicol; 2024; 6():1376118. PubMed ID: 38938663
[No Abstract] [Full Text] [Related]
2. Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of tobacco and other nicotine-containing products.
Miller-Holt J; Behrsing HP; Clippinger AJ; Hirn C; Stedeford TJ; Stucki AO
Front Toxicol; 2022; 4():943358. PubMed ID: 36157974
[TBL] [Abstract][Full Text] [Related]
3. Key Challenges and Recommendations for
Moore MM; Abraham I; Ballantyne M; Behrsing H; Cao X; Clements J; Gaca M; Gillman G; Hashizume T; Heflich RH; Hurtado S; Jordan KG; Leverette R; McHugh D; Miller-Holt J; Phillips G; Recio L; Roy S; Scian M; Simms L; Smart DJ; Stankowski LF; Tarran R; Thorne D; Weber E; Wieczorek R; Yoshino K; Curren R
Altern Lab Anim; 2023 Jan; 51(1):55-79. PubMed ID: 36821083
[TBL] [Abstract][Full Text] [Related]
4. Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry.
Miller-Holt J; Behrsing H; Crooks I; Curren R; Demir K; Gafner J; Gillman G; Hollings M; Leverette R; Oldham M; Simms L; Stankowski LF; Thorne D; Wieczorek R; Moore MM
Drug Test Anal; 2023 Oct; 15(10):1175-1188. PubMed ID: 35830202
[TBL] [Abstract][Full Text] [Related]
5. Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes.
Simms L; Mason E; Berg EL; Yu F; Rudd K; Czekala L; Trelles Sticken E; Brinster O; Wieczorek R; Stevenson M; Walele T
Curr Res Toxicol; 2021; 2():309-321. PubMed ID: 34485931
[TBL] [Abstract][Full Text] [Related]
6. Key Challenges for
Crooks I; Clements J; Curren R; Guo X; Hollings M; Lloyd M; Smart D; Thorne D; Weber E; Moore M
Altern Lab Anim; 2024 Jan; 52(1):42-59. PubMed ID: 38055860
[TBL] [Abstract][Full Text] [Related]
7. Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: "What Are the Tools Needed for the Job?" and "Do We Have Them?".
Chandy M; Hill T; Jimenez-Tellez N; Wu JC; Sarles SE; Hensel E; Wang Q; Rahman I; Conklin DJ
Cardiovasc Toxicol; 2024 May; 24(5):435-471. PubMed ID: 38555547
[TBL] [Abstract][Full Text] [Related]
8. Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products.
Simms L; Yu F; Palmer J; Rudd K; Sticken ET; Wieczorek R; Chapman F; Czekala L; Stevenson M; O'Connell G
Front Toxicol; 2022; 4():747508. PubMed ID: 35295225
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the borgwaldt LM4E system for in vitro exposures to undiluted aerosols from next generation tobacco and nicotine products (NGPs).
Adamson J; Jaunky T; Thorne D; Gaça MD
Food Chem Toxicol; 2018 Mar; 113():337-344. PubMed ID: 29421647
[TBL] [Abstract][Full Text] [Related]
10. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
[TBL] [Abstract][Full Text] [Related]
11. Influence of machine-based puffing parameters on aerosol and smoke emissions from next generation nicotine inhalation products.
McAdam K; Davis P; Ashmore L; Eaton D; Jakaj B; Eldridge A; Liu C
Regul Toxicol Pharmacol; 2019 Feb; 101():156-165. PubMed ID: 30445136
[TBL] [Abstract][Full Text] [Related]
12. Tobacco-Free Nicotine Pouches and Their Potential Contribution to Tobacco Harm Reduction: A Scoping Review.
Grandolfo E; Ogden H; Fearon IM; Malt L; Stevenson M; Weaver S; Nahde T
Cureus; 2024 Feb; 16(2):e54228. PubMed ID: 38496069
[TBL] [Abstract][Full Text] [Related]
13. In vitro exposure systems and dosimetry assessment tools for inhaled tobacco products: Workshop proceedings, conclusions and paths forward for in vitro model use.
Behrsing H; Hill E; Raabe H; Tice R; Fitzpatrick S; Devlin R; Pinkerton K; Oberdörster G; Wright C; Wieczorek R; Aufderheide M; Steiner S; Krebs T; Asgharian B; Corley R; Oldham M; Adamson J; Li X; Rahman I; Grego S; Chu PH; McCullough S; Curren R
Altern Lab Anim; 2017 Jul; 45(3):117-158. PubMed ID: 28816053
[TBL] [Abstract][Full Text] [Related]
14. Advancing New Approach Methodologies (NAMs) for Tobacco Harm Reduction: Synopsis from the 2021 CORESTA SSPT-NAMs Symposium.
Lee KM; Corley R; Jarabek AM; Kleinstreuer N; Paini A; Stucki AO; Bell S
Toxics; 2022 Dec; 10(12):. PubMed ID: 36548593
[TBL] [Abstract][Full Text] [Related]
15. Challenges in current inhalable tobacco toxicity assessment models: A narrative review.
Muthumalage T; Noel A; Thanavala Y; Alcheva A; Rahman I
Tob Induc Dis; 2024; 22():. PubMed ID: 38860150
[TBL] [Abstract][Full Text] [Related]
16. An inter-laboratory in vitro assessment of cigarettes and next generation nicotine delivery products.
Ito S; Taylor M; Mori S; Thorne D; Nishino T; Breheny D; Gaça M; Yoshino K; Proctor C
Toxicol Lett; 2019 Oct; 315():14-22. PubMed ID: 31400404
[TBL] [Abstract][Full Text] [Related]
17. Looking Back and Ahead: The Food and Drug Administration's Regulation of the Tobacco Industry and Next-Generation Products.
Jacob M
Adv Dent Res; 2019 Oct; 30(1):22-25. PubMed ID: 31538803
[TBL] [Abstract][Full Text] [Related]
18. Nonanimal toxicology testing approaches for traditional and deemed tobacco products in a complex regulatory environment: Limitations, possibilities, and future directions.
Lauterstein D; Savidge M; Chen Y; Weil R; Yeager RP
Toxicol In Vitro; 2020 Feb; 62():104684. PubMed ID: 31618670
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products.
Akiyama Y; Sherwood N
Toxicol Rep; 2021; 8():282-294. PubMed ID: 33552927
[TBL] [Abstract][Full Text] [Related]
20. Evolution of tobacco products: recent history and future directions.
O'Connor R; Schneller LM; Felicione NJ; Talhout R; Goniewicz ML; Ashley DL
Tob Control; 2022 Mar; 31(2):175-182. PubMed ID: 35241585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
